These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17094473)

  • 1. Pharmacological and toxicological evaluation of a new series of thymidylate synthase inhibitors as anticancer agents.
    Benassi L; Magnoni C; Giudice S; Bertazzoni G; Costi MP; Rinaldi M; Venturelli A; Coppi A; Rossi T
    Anticancer Res; 2006; 26(5A):3499-504. PubMed ID: 17094473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New thymidylate synthase inhibitors induce apoptosis in melanoma cell lines.
    Giudice S; Benassi L; Bertazzoni G; Costi MP; Gelain A; Venturelli A; Bernardi C; Gualdi G; Coppi A; Rossi T; Giannetti A; Magnoni C
    Toxicol In Vitro; 2007 Mar; 21(2):240-8. PubMed ID: 17118621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ortho-Halogen naphthaleins as specific inhibitors of Lactobacillus casei thymidylate synthase. Conformational properties and biological activity.
    Ghelli S; Rinaldi M; Barlocco D; Gelain A; Pecorari P; Tondi D; Rastelli G; Costi MP
    Bioorg Med Chem; 2003 Mar; 11(6):951-63. PubMed ID: 12614880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and antitumor activity of new bis-aminomethylnaphthalenes.
    Bollini M; Casal JJ; Bruno AM
    Bioorg Med Chem; 2008 Sep; 16(17):8003-10. PubMed ID: 18715786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents.
    Gangjee A; Jain HD; McGuire JJ; Kisliuk RL
    J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 9,10-dihydroxy-4,4-dimethyl-5,8-dihydro-1(4H)-anthracenone derivatives on tumor cell respiration.
    Araya-Maturana R; Cardona W; Cassels BK; Delgado-Castro T; Ferreira J; Miranda D; Pavani M; Pessoa-Mahana H; Soto-Delgado J; Weiss-López B
    Bioorg Med Chem; 2006 Jul; 14(13):4664-9. PubMed ID: 16504517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of cyclic diamidines with different core-substituents as antitumor agents.
    Spychała J
    Bioorg Chem; 2008 Aug; 36(4):183-9. PubMed ID: 18571215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumour activity of fluorinated 1-aza and 1,8-diazaanthraquinones.
    Ramos MT; Díaz-Guerra LM; García-Copín S; Avendaño C; García-Grávalos D; García de Quesada T
    Farmaco; 1996 May; 51(5):375-9. PubMed ID: 8767848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
    Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
    J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
    Koehler SE; Ladner RD
    Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
    Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
    Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
    Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones.
    Xiao ZP; Li HQ; Shi L; Lv PC; Song ZC; Zhu HL
    ChemMedChem; 2008 Jul; 3(7):1077-82. PubMed ID: 18433075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase as a molecular target for drug discovery using the National Cancer Institute's Anticancer Drug Screen.
    Parr AL; Myers TG; Holbeck SL; Loh YJ; Allegra CJ
    Anticancer Drugs; 2001 Aug; 12(7):569-74. PubMed ID: 11487712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition.
    Costi PM; Rinaldi M; Tondi D; Pecorari P; Barlocco D; Ghelli S; Stroud RM; Santi DV; Stout TJ; Musiu C; Marangiu EM; Pani A; Congiu D; Loi GA; La Colla P
    J Med Chem; 1999 Jun; 42(12):2112-24. PubMed ID: 10377217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
    Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
    J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.